Oncology Clinical Trials in Ypsilanti, MI
As of August 2026, 33 paid clinical trials are recruiting for Oncology in Ypsilanti, Michigan. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
33 clinical trials for Oncology
·Clear filters·A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Study of ASP3082 in Adults With Advanced Solid Tumors
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Top Research Study Locations in Ypsilanti
Researchers run research studies in Ypsilanti, MI at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 83 |
| Huron Gastroenterology PC | Anatomic Stage II Breast Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | 42 |
| Michigan Heart | Hypertension, Hypertension, Essential, Hypertension, Systolic | 3 |
| Trinity Health | Atrial Fibrillation, Atrial Fibrillation, Postoperative, HR+/HER2-negative Breast Cancer | 3 |
| Trinity Health Ann Arbor Hospital | AV Block, Atrial Fibrillation, Bradycardia | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Huron Gastroenterology Associates, P.C. | Crohn's Disease, Ulcerative Colitis | 2 |
| Trinity Health Michigan Heart | Diabetes Mellitus, Type 2, Heart Failure, Metabolic Syndrome | 2 |
| Trinity Health Michigan Heart - Ann Arbor Campus | Atrial Fibrillation, Leukemia, Myeloid, Acute | 2 |
| Allergy & Immunology Associates of Ann Arbor | Dermatitis Atopic | 1 |
| Dawn Farm | Alcohol Use Disorder, Criminal Behavior, Health Risk Behaviors | 1 |
| Forest Health Medical Center | Lumbar Spinal Stenosis | 1 |
| Huron Gastro | Crohn's Disease, Ulcerative Colitis | 1 |
| Investigative | Solid Tumors | 1 |
| Michigan Heart, PC | Heart Failure | 1 |
| Michigan Otolaryngology Surgery Associates | Tonsillectomy | 1 |
| Mirador Therapeutics Selected Site | Crohn's Disease, Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC) | 1 |
| Research | Severe Asthma | 1 |
| Respiratory Medicine Research Institute of Michigan PLC | Chronic Spontaneous Urticaria | 1 |
| Respiratory Medicine Research Institute of Michigan, PLC | Atopic Dermatitis, Eczema | 1 |
| Saint Joseph Mercy Ann Arbor | Coronary Artery Disease | 1 |
| St. Joseph Mercy Health System | Aortic Stenosis, Coronary Artery Disease, Coronary Stenosis | 1 |
| St. Joseph Mercy Hospital - Huron Gastroenterology Associates | Colitis, Ulcerative, Crohn Disease | 1 |
| Tenax Investigational Site | Pulmonary Hypertension Associated With HFpEF | 1 |
| Trinity Ann Arbor d/b/a Michigan Heart Ann Arbor | Heart Failure | 1 |
Active & Upcoming Studies in Ypsilanti (2026)
Recruiting trials in Ypsilanti grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (81 active studies)
- Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) · Phase 2 · National Cancer Institute (NCI)
- Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial) · Phase 2 · National Cancer Institute (NCI)
Cardiovascular (22 active studies)
Diabetes & metabolic (4 active studies)
Common conditions studied in Ypsilanti
- Acute Myeloid Leukemia (7 active studies)
- Heart Failure (7 active studies)
- Stage IV Lung Cancer AJCC v8 (7 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (5 active studies)
- Atrial Fibrillation (4 active studies)
- Lung Non-Small Cell Carcinoma (4 active studies)
Leading research sponsors in Ypsilanti
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- SWOG Cancer Research Network
- NRG Oncology
- ECOG-ACRIN Cancer Research Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Ypsilanti?
There are approximately 134 recruiting clinical trials in Ypsilanti, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Ypsilanti pay participants?
Most recruiting trials in Ypsilanti compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Ypsilanti?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Ypsilanti?
The most common conditions under active study in Ypsilanti include Acute Myeloid Leukemia (7), Heart Failure (7), Stage IV Lung Cancer AJCC v8 (7), Anatomic Stage II Breast Cancer AJCC v8 (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Ypsilanti?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Ypsilanti on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Ypsilanti?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Ypsilanti?
Recruiting research sites in Ypsilanti include Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Huron Gastroenterology PC, Michigan Heart, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Ypsilanti right now?
The largest active categories in Ypsilanti are Cancer & tumors (81), Cardiovascular (22), Diabetes & metabolic (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.